Latest Us Regulatory News

Brookside Energy reported a 50% increase in Proved Developed Producing reserves and steady production in Q1 2025, while progressing preparations for a US listing on the NYSE.

LTR Pharma reports strong Q1 2025 progress with FDA pre-IND meeting success, scientific acclaim for SPONTAN’s rapid absorption, and strategic launch of ROXUS to fast-track US market entry.

Australian Oil Company Limited (AOK) reports significant progress in its California pipeline acquisition and appoints Chris Hodge as Non-Executive Chairman, signaling a strategic push into US gas exploration.

EQ Resources Limited reported a record quarterly tungsten concentrate production of 33,249 mtu, driven by operational excellence at its Saloro mine and strategic acquisitions including Tungsten Metals Group Ltd. Despite challenges at Mt Carbine due to low rainfall, the company secured significant funding and is poised for growth.

Pacific Edge announces a two-month delay in the Medicare Local Coverage Determination for its genetic oncology tests, extending the effective date to April 24, 2025. This extension follows the company’s active engagement with US regulatory bodies.